R. E. Davis

480 total citations
19 papers, 336 citations indexed

About

R. E. Davis is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, R. E. Davis has authored 19 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Oncology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in R. E. Davis's work include Neuropeptides and Animal Physiology (4 papers), Hormonal Regulation and Hypertension (3 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers). R. E. Davis is often cited by papers focused on Neuropeptides and Animal Physiology (4 papers), Hormonal Regulation and Hypertension (3 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers). R. E. Davis collaborates with scholars based in Australia, United States and United Kingdom. R. E. Davis's co-authors include Roger A. Warnke, Ronald F. Dorfman, Peter L. Greenberg, John Davies, Graham Macdonald, Katherine A. Duggan, Robert Wilson, Dylan M. Jones, ML Cleary and RA Warnke and has published in prestigious journals such as Blood, The Journal of Physiology and Cancer.

In The Last Decade

R. E. Davis

19 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. E. Davis Australia 10 118 67 65 61 58 19 336
S Zecca Italy 6 72 0.6× 105 1.6× 60 0.9× 97 1.6× 18 0.3× 6 412
Kenichiro Matoba Japan 10 54 0.5× 27 0.4× 66 1.0× 93 1.5× 31 0.5× 13 344
Kentaro Tsunamoto Japan 10 40 0.3× 86 1.3× 106 1.6× 139 2.3× 62 1.1× 26 514
Maja Barbalić Croatia 12 31 0.3× 96 1.4× 104 1.6× 81 1.3× 22 0.4× 28 453
Pelin Adıyaman Türkiye 13 39 0.3× 183 2.7× 25 0.4× 158 2.6× 35 0.6× 40 450
Antonio G. Tristano Venezuela 11 43 0.4× 25 0.4× 73 1.1× 30 0.5× 25 0.4× 25 454
Jennifer Hanson United States 6 22 0.2× 23 0.3× 30 0.5× 92 1.5× 80 1.4× 14 425
Mehmet Akif Özdemir Türkiye 10 27 0.2× 29 0.4× 78 1.2× 29 0.5× 30 0.5× 34 272
José Rafael Villafán-Bernal Mexico 13 36 0.3× 49 0.7× 22 0.3× 80 1.3× 44 0.8× 46 417
Monique G. Zaahl South Africa 12 28 0.2× 49 0.7× 44 0.7× 68 1.1× 21 0.4× 20 401

Countries citing papers authored by R. E. Davis

Since Specialization
Citations

This map shows the geographic impact of R. E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. E. Davis more than expected).

Fields of papers citing papers by R. E. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. E. Davis. The network helps show where R. E. Davis may publish in the future.

Co-authorship network of co-authors of R. E. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of R. E. Davis. A scholar is included among the top collaborators of R. E. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. E. Davis. R. E. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Davis, R. E. & Douglas Evans. (2018). Associations between mass incarceration and community health in New York City. Public Health. 161. 43–48. 4 indexed citations
2.
Davis, R. E., et al.. (2016). Impact of Health-Related Quality of Life and Social Determinants on Yearly Influenza Immunization in the United States. Value in Health. 19(3). A221–A221. 5 indexed citations
3.
Davis, R. E., et al.. (2015). A critical review of low‐carbohydrate diets in people with Type 2 diabetes. Diabetic Medicine. 33(2). 148–157. 67 indexed citations
4.
Davis, R. E., et al.. (2006). Insulin initiation among adults and children with diabetes in the United Kingdom. Practical Diabetes International. 23(4). 171–174. 5 indexed citations
5.
Kramarz, Piotr, Frank DeStefano, Paul Gargiullo, et al.. (2000). oes influenza vaccination exacerbate asthma. Archives of Family Medicine. 9. 8 indexed citations
6.
Davis, R. E. & Peter L. Greenberg. (1998). Bcl-2 expression by myeloid precursors in myelodysplastic syndromes: relation to disease progression. Leukemia Research. 22(9). 767–777. 52 indexed citations
7.
Soslow, Robert A., et al.. (1996). True histiocytic lymphoma following therapy for lymphoblastic neoplasms. Blood. 87(12). 5207–5212. 26 indexed citations
8.
Davis, R. E., et al.. (1995). Vasoactive intestinal peptide regulates angiotensin II catabolism in the rabbit. Acta Physiologica Scandinavica. 153(3). 255–261. 4 indexed citations
9.
Duggan, Katherine A., et al.. (1995). Effects of Endopeptidase 24.11 Inhibition on Plasma and Tissue Concentrations of Vasoactive Intestinal Peptide. Clinical Science. 89(3). 267–271. 11 indexed citations
10.
Duggan, Katherine A., Dylan M. Jones, R. E. Davis, & Graham Macdonald. (1994). EFFECT OF NEUTRAL ENDOPEPTIDASE ON PLASMA AND TISSUE CONCENTRATIONS OF VASO‐ACTIVE INTESTINAL PEPTIDE. Clinical and Experimental Pharmacology and Physiology. 21(4). 307–309. 11 indexed citations
11.
Davis, R. E., Graham Macdonald, & Katherine A. Duggan. (1992). Angiotensin II regulates the metabolism but not the secretion of vasoactive intestinal peptide in the rabbit. Clinical Science. 83(5). 557–560. 5 indexed citations
12.
Davis, R. E., et al.. (1992). The effects of a high sodium diet on the metabolism and secretion of vasoactive intestinal peptide in the rabbit.. The Journal of Physiology. 451(1). 17–23. 10 indexed citations
13.
Davis, R. E., Roger A. Warnke, & Ronald F. Dorfman. (1991). Inflammatory Pseudotumor of Lymph Nodes. The American Journal of Surgical Pathology. 15(8). 744–756. 46 indexed citations
14.
Davis, R. E., Roger A. Warnke, Ronald F. Dorfman, & Michael L. Cleary. (1991). Utility of molecular genetic analysis for the diagnosis of neoplasia in morphologically and immunophenotypically equivocal hematolymphoid lesions. Cancer. 67(11). 2890–2899. 9 indexed citations
15.
Davis, R. E., Ronald F. Dorfman, & Roger A. Warnke. (1990). Primary large-cell lymphoma of the thymus. Human Pathology. 21(12). 1262–1268. 33 indexed citations
16.
Wilson, Robert & R. E. Davis. (1984). Vitamin B6 Intake and Plasma Pyridoxal Phosphate Concentrations in the First 2 Weeks of Life. Acta Paediatrica. 73(2). 218–224. 11 indexed citations
17.
McCann, V. J., R. E. Davis, Timothy A. Welborn, Ian J. Constable, & D. Beale. (1981). Glyoxalase Phenotypes in Patients with Diabetes Mellitus. Australian and New Zealand Journal of Medicine. 11(3). 380–382. 20 indexed citations
18.
Davis, R. E., et al.. (1978). ILLEGAL DRUGS AND NUTRITION IN UNDERGRADUATE STUDENTS. The Medical Journal of Australia. 1(11). 617–620. 6 indexed citations
19.
Holt, John A., et al.. (1967). Radiation and Marrow Infusion in Leukaemia. Australasian Radiology. 11(1). 63–66. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026